Digital Individualized and Collaborative Treatment (DICTA) RCT aims to optimize T2D management in general practice

Effective management of Type 2 Diabetes (T2D) requires multifactorial intervention, often falling short in general practice due to limited resources for individualized care. Patients with T2D face a high risk of cardiovascular disease (CVD), necessitating optimized control of glycemic parameters, hypertension, and hypercholesterolemia. Current standard-of-care often lacks the integrated, real-time, and personalized support needed to sustain lifestyle changes and tailor pharmacological treatments effectively. This project addresses this gap by integrating specialist-supervised treatment, individual patient coaching, and data-driven decision support directly into general practice IT systems.

This randomized controlled trial (RCT) will enroll 400 patients with newly diagnosed type 2 diabetes. The intervention group will receive the DICTA system, comprising two integrated components: a patient-directed eHealth lifestyle coaching program via the LIVA application, and a clinician-directed Clinical Decision Support (CDS) tool embedded into the general practitioner's EPJ (Electronic Patient Journal) system. Patients in the intervention arm will receive individualized digital coaching from a health coach, with Patient-Reported Outcomes (PROs) shared with GPs. GPs will receive real-time, algorithm-based pharmacological treatment recommendations for T2D, hypertension, and hypercholesterolemia. The control group will receive usual care. After one year, researchers will assess quality of life and cardiovascular risk factors in both groups to evaluate improved T2D management.